Literature DB >> 34908201

Increased nasal epithelial cell responsiveness to IL-17A in paediatric asthmatics with low blood neutrophil count, low traffic-related air pollution exposure and good asthma control.

Jaclyn W McAlees1, Theresa Baker2, Lauren Houshel1, Christopher McKnight3,4, Andrew Lindsley5,6, Richard T Strait7, Xue Zhang8, Angela Cannata1,9, Jocelyn M Biagini2,6, Melinda Butsch Kovacic2,6,10, Ian P Lewkowich1,6.   

Abstract

Entities:  

Keywords:  IL-17A; asthma; epithelial cells; paediatrics

Mesh：

Substances：

Year:  2021        PMID： 34908201      PMCID： PMC8976742          DOI： 10.1111/cea.14080

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  10 in total

1.  Age and early maternal smoking contribute to epithelial cell IL-13 responsiveness in a pediatric asthma population.

Authors:  Jaclyn W McAlees; Theresa Baker; Davinder Kaur; Christopher McKnight; Andrew Lindsley; Richard T Strait; Xue Zhang; Jocelyn M Biagini Myers; Melinda Butsch Kovacic; Ian P Lewkowich
Journal:  Allergy       Date:  2019-07-02       Impact factor: 13.146

2.  IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation.

Authors:  Sara L Hall; Theresa Baker; Stephane Lajoie; Phoebe K Richgels; Yanfen Yang; Jaclyn W McAlees; Adelaide van Lier; Marsha Wills-Karp; Umasundari Sivaprasad; Thomas H Acciani; Timothy D LeCras; Jocelyn Biagini Myers; Melinda Butsch Kovacic; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2016-06-11       Impact factor: 10.793

3.  Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma.

Authors:  Chaoyu Irvin; Iram Zafar; James Good; Donald Rollins; Christina Christianson; Magdalena M Gorska; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2014-07-18       Impact factor: 10.793

4.  Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

5.  Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies.

Authors:  Catherine M McDougall; Morgan G Blaylock; J Graham Douglas; Richard J Brooker; Peter J Helms; Garry M Walsh
Journal:  Am J Respir Cell Mol Biol       Date:  2008-05-15       Impact factor: 6.914

Review 6.  IL-17 in severe asthma. Where do we stand?

Authors:  Julie Chesné; Faouzi Braza; Guillaume Mahay; Sophie Brouard; Marc Aronica; Antoine Magnan
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

7.  Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells.

Authors:  Ashley Ulm; Christopher N Mayhew; Jason Debley; Gurjit K Khurana Hershey; Hong Ji
Journal:  J Vis Exp       Date:  2016-03-10       Impact factor: 1.355

8.  Diesel exhaust particle induction of IL-17A contributes to severe asthma.

Authors:  Eric B Brandt; Melinda Butsch Kovacic; Gerald B Lee; Aaron M Gibson; Thomas H Acciani; Timothy D Le Cras; Patrick H Ryan; Alison L Budelsky; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2013-09-20       Impact factor: 10.793

9.  Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma.

Authors:  Stephane Lajoie; Ian P Lewkowich; Yusuke Suzuki; Jennifer R Clark; Alyssa A Sproles; Krista Dienger; Alison L Budelsky; Marsha Wills-Karp
Journal:  Nat Immunol       Date:  2010-08-29       Impact factor: 25.606

10.  Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function.

Authors:  Cecilia K Andersson; Alexandra Adams; Prasad Nagakumar; Cara Bossley; Atul Gupta; Daphne De Vries; Afiqah Adnan; Andrew Bush; Sejal Saglani; Clare M Lloyd
Journal:  J Allergy Clin Immunol       Date:  2016-10-13       Impact factor: 10.793
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.